AORT
Artivion, Inc.Company with tickers: AORT
CIK
784199
CUSIP
228903100
Shares Outstanding
48,543,350
Website
https://www.artivion.com
13F Activity (30d)
26 filings
6 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-06-11 | GREEN ANDREW M |
VP Regulatory | Sell | 30,000 |
| 2026-06-11 | GREEN ANDREW M |
VP Regulatory | Convert | 30,000 |
| 2026-06-11 | GREEN ANDREW M |
VP Regulatory | Convert | 14,001 |
| 2026-06-11 | GREEN ANDREW M |
VP Regulatory | Sell | 14,001 |
| 2026-06-11 | GREEN ANDREW M |
VP Regulatory | Convert | 14,001 |
| 2026-06-11 | GREEN ANDREW M |
VP Regulatory | Convert | 30,000 |
| 2026-06-02 | SEMEDO ANTHONY B. |
Director | Other | 6,325 |
| 2026-06-02 | SEMEDO ANTHONY B. |
Director | Other | 6,325 |
| 2026-05-18 | Burbank Jeffrey H |
Director | Award | 7,576 |
| 2026-05-18 | Salveson Jon W |
Director | Award | 7,576 |
| 2026-05-18 | SEMEDO ANTHONY B. |
Director | Award | 7,576 |
| 2026-05-18 | BEVEVINO DANIEL J |
Director | Award | 7,576 |
| 2026-05-18 | ACKERMAN THOMAS F |
Director | Award | 7,576 |
| 2026-05-18 | Hoff Elizabeth A |
Director | Award | 7,576 |
| 2026-05-18 | Bullock James |
Director | Award | 7,576 |
| 2026-05-14 | Borgstrom Marna P |
Director | Award | 7,850 |
| 2026-03-04 | Holloway Jean F |
SVP, General Counsel | Sell | 8,962 |
| 2026-03-03 | Davis John E |
Chief Commercial Officer | Sell | 4,573 |
| 2026-03-03 | Stanton Marshall S. |
SVP, Clinical & MD Affair | Sell | 2,149 |
| 2026-03-03 | Holloway Jean F |
SVP, General Counsel | Sell | 3,843 |
| 2026-03-03 | Berry Lance A |
Director | Sell | 6,316 |
| 2026-03-03 | Horton Amy |
VP, Chief Accounting Officer | Sell | 901 |
| 2026-03-03 | Mackin James P |
President & CEO | Sell | 17,887 |
| 2026-03-02 | Horton Amy |
VP, Chief Accounting Officer | Award | 7,475 |
| 2026-03-02 | Mackin James P |
President & CEO | Sell | 14,911 |
| 2026-03-02 | Holloway Jean F |
SVP, General Counsel | Sell | 2,183 |
| 2026-03-02 | Holloway Jean F |
SVP, General Counsel | Award | 27,795 |
| 2026-03-02 | Mackin James P |
President & CEO | Award | 116,948 |
| 2026-03-02 | Berry Lance A |
Director | Award | 40,874 |
| 2026-03-02 | Davis John E |
Chief Commercial Officer | Award | 28,845 |
| 2026-03-02 | Horton Amy |
VP, Chief Accounting Officer | Sell | 641 |
| 2026-03-02 | Stanton Marshall S. |
SVP, Clinical & MD Affair | Award | 21,838 |
| 2026-03-02 | Stanton Marshall S. |
SVP, Clinical & MD Affair | Sell | 1,513 |
| 2026-03-02 | Davis John E |
Chief Commercial Officer | Sell | 2,784 |
| 2026-03-02 | Berry Lance A |
Director | Sell | 5,178 |
| 2026-02-24 | Holloway Jean F |
SVP, General Counsel | Sell | 1,668 |
| 2026-02-24 | Horton Amy |
VP, Chief Accounting Officer | Award | 5,658 |
| 2026-02-24 | Davis John E |
Chief Commercial Officer | Sell | 2,075 |
| 2026-02-24 | Stanton Marshall S. |
SVP, Clinical & MD Affair | Sell | 1,259 |
| 2026-02-24 | Davis John E |
Chief Commercial Officer | Award | 20,438 |
| 2026-02-24 | Berry Lance A |
Director | Award | 37,482 |
| 2026-02-24 | Mackin James P |
President & CEO | Sell | 13,936 |
| 2026-02-24 | Horton Amy |
VP, Chief Accounting Officer | Sell | 830 |
| 2026-02-24 | Berry Lance A |
Director | Sell | 4,485 |
| 2026-02-24 | Mackin James P |
President & CEO | Award | 97,030 |
| 2026-02-24 | Holloway Jean F |
SVP, General Counsel | Award | 20,085 |
| 2026-02-23 | Berry Lance A |
Director | Sell | 4,981 |
| 2026-02-23 | Holloway Jean F |
SVP, General Counsel | Sell | 3,079 |
| 2026-02-23 | Mackin James P |
President & CEO | Sell | 20,962 |
| 2026-02-23 | Davis John E |
Chief Commercial Officer | Sell | 3,773 |
Showing 1–50 of 821 transactions